Iopamidol과 Ioversol 제제 조영제의 온도변화에 따른 물리화학적 분석
Physicochemical Analysis according to Temperature Changes of Iopamidol and Ioversol Formulation Contrast Agents
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
In this study, the P contrast agent of Iopamidol, which is a nonionic iodide contrast agent most commonly used as a vascular contrast agent in medical institutions, and the O contrast agent of Ioversol, were studied. The physicochemical changes according to the temperature change were compared and analyzed using the Bruker Avance 500MHz Nuclear Magnetic Resonance Spectrometer owned by the Korea Basic Science Institute (KBSI). There was no physical or chemical change in the O contrast medium of Ioversol formulation in temperature change. However, in the P contrast agent of Iopamidol, a doublet peak began to appear in the 1.1 ppm region of the sample at 60℃, and the doublet peak was clearly observed in the sample at 80℃. As a result of this study, 1H-NMR analysis revealed that the P contrast agent of the Iopamidol formulation was dissociated from chemical bonds as it rose to a high temperature of 60℃ or higher, resulting in the formation of foreign substances. It was evaluated that the O contrast agent of Ioversol formulation had physico-chemical stability than the P contrast agent of Iopamidol formulation. As shown in this study, it is necessary to analyze the physical and chemical changes of contrast agents according to various environmental factors.
Abstract
In this study, the P contrast agent of Iopamidol, which is a nonionic iodide contrast agent most commonly used as a vascular contrast agent in medical institutions, and the O contrast agent of Ioversol, were studied. The physicochemical changes according to the temperature change were compared and analyzed using the Bruker Avance 500MHz Nuclear Magnetic Resonance Spectrometer owned by the Korea Basic Science Institute (KBSI). There was no physical or chemical change in the O contrast medium of Ioversol formulation in temperature change. However, in the P contrast agent of Iopamidol, a doublet peak began to appear in the 1.1 ppm region of the sample at 60℃, and the doublet peak was clearly observed in the sample at 80℃. As a result of this study, 1H-NMR analysis revealed that the P contrast agent of the Iopamidol formulation was dissociated from chemical bonds as it rose to a high temperature of 60℃ or higher, resulting in the formation of foreign substances. It was evaluated that the O contrast agent of Ioversol formulation had physico-chemical stability than the P contrast agent of Iopamidol formulation. As shown in this study, it is necessary to analyze the physical and chemical changes of contrast agents according to various environmental factors.
참고문헌 (24)
- ESUR Contrast Media Safety Committee, "ESUR guidelines on contrast media", European Society of Urogenital Radiology, ~ (2007)
- Ko IH, "Textbook computed tomography" (2005), Chung-Ku Publisher
- 박창묵, "방사선 검사에 사용되는 조영제 Iopamidol의 안전성 평가", 약 학 회 지, 53(6), pp.328~333 (2009), 대한약학회
- 양원석, "MDCT에 사용되는 조영제의 부작용에 대한 고찰", 방사선기술과학, 35(1), pp.51~57 (2012), 대한방사선과학회
- 권대철, "CT 조영제의 부작용 예방을 위한 표준진료지침서의 개발과 적용", 방사선기술과학, 30(1), pp.39~46 (2007), 대한방사선과학회
- 강영한, "조영제 부작용에 대한 주의의무와 제조물책임", 방사선기술과학, 30(4), pp.305~311 (2007), 대한방사선과학회
- 권기수, "컴퓨터 단층촬영(Computed Tomography)에 사용되는 조영제의 부작용 발생에 대한 분석", 석사, 임상전문간호학, pp.2004
- Wieten DM, "Acute reaction to urographic contrast medium : Incidence, clinical characteristics and relationships to hypersensitivity states", Am J Roentgenol, 119, pp.832~840 (1973)
- Siegle R, "The use of iohexol in patients with previous reactions to ionic contrast material", Invest Radiol, 26, pp.411~416 (1991)
- Dawson P, "Textbook contrast media" (1999), British Library
- Lee SK, "The analysis of NMR spectrum" (2014), Hanrimwon
- Hyun-Sook Hong, "Clinical Application of Intravascular Administration of Non-ionic, Low Osmolar Contrast Agent, Ioversol(Optiray 320)and Its Side Effects Comparison with Meglumine Iothalamate(Conray 60)", Journal of Korean Radiological Society, 26(6), pp.1284~1290 (1990)
- "Dongkook Life Science" (2019)[URL]
- "Ministry of Food and Drug Safety" (2017)[URL]
- Thomas AMK, "The invisible light, 100 year of medical radiology", pp.13~18 (1995), Blackwell Science
- Swick M, "Radiographic media in urology, the discovery of excretion urography", Surg Clin N Am, 58, pp.977~994 (1978)
- Swick M, "Darstellung der Niere und Harnwege in Roentgenbild durch intravenose Einbringung eines Kontraststoffes : Des Uroselectans", Klin uanau Wochenschr, 8, pp.2087~2089 (1929)
- Von Lichtenberg A, "Klinische Prüfung des Uroselectans", Klin Wochenschr, 8, pp.2089~2091 (1929)
- Wallingford VH, "The development of organic iodide compounds as X-ray contrast media", J Am Pharm Assoc(Scientific Edition), 42, pp.721~728 (1953)
- Almén T, "Contrast agent design. Some aspects on the synthesis of water-soluble contrast agents of low osmolality", J Theor Biol, 24, pp.216~226 (1969)
- 김영덕, "CT조영검사에서 조영제 부작용의 실태와 관련요인 조사", 석사, 보건학, pp.2005
- Kyung Eun Jung, "A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea", Annals of Dermatology, 24(1), pp.22~25 (2012), 대한피부과학회
- Dyvik K, "Relationship between viscosity and determined injection pressure in angio-graphic catheters for common roentgen contrast media", Acta Radiologica Suppl, 36, pp.43~49 (1995)
- Smedby O, "Viscosity of some contemporary contrast media before and after mixing with whole blood", Acta Radiol, 33, pp.600~605 (1992)